In the BioHarmony Drug Report Database

"Preview" Icon

Entacapone

Comtan, Comtess, Entacapone Orion (entacapone) is a small molecule pharmaceutical. Entacapone was first approved as Comtan on 1998-09-16. It is used to treat parkinson disease in the USA. It has been approved in Europe to treat parkinson disease. The pharmaceutical is active against catechol O-methyltransferase. In addition, it is known to target alpha-ketoglutarate-dependent dioxygenase FTO.

 

Trade Name

 

Comtan, Comtess, Entacapone Orion
 

Common Name

 

entacapone
 

ChEMBL ID

 

CHEMBL953
 

Indication

 

parkinson disease
 

Drug Class

 

Catechol-O-methyltransferase (COMT) inhibitors

Image (chem structure or protein)

Entacapone structure rendering